Injective, the DeFi-centric protocol, has recently been rejected from the 200-day EMA cluster and resembles bearishness. The chances of a successful breakout are bleak. The INJ price has moved below the key EMAs, guiding selling pressure throughout the week. It stagnated in a significant range and could not climb above the $23 mark amid multiple…
Injective, the DeFi-centric protocol, has recently made major moves. Besides boasting of high throughput and low fees while protecting traders from maximal extractive value (MEV) bots, the platform has been striking key partnerships. Injective Integrates With Fetch.ai And ASI This week, the proposal by Fetch.ai and the Artificial Superintelligence Alliance (ASI) community to integrate Injective…
The Injective collaboration with NTT Digital aims to enhance Injective’s credibility and resources in the Web3 space, bolstering its position in DeFi. The involvement of NTT Digital will accelerate Injective’s expansion and improve the platform’s security and scalability. Injective, a layer-1 blockchain built on the Cosmos network, has announced a major partnership with NTT Digital,…
Injective (INJ) crypto has grabbed attention with its current market move. It trades close to the declining trendline barrier of the channel, close to $20. Notably, INJ price was dealing closer to the make-or-break zone and aimed for a breakout. INJ has been moving within a channel for the last three months, consistently facing resistance…
Este artículo también está disponible en español. Injective (INJ) has been outperforming the broader crypto market in recent hours, gaining over 19% since Monday, while most cryptocurrencies have experienced declines of 2% to 4% since yesterday. Related Reading This strong performance comes after the altcoin broke through the $18 resistance level, signaling bullish momentum. Investors…